L Verbist
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Adverse Reactions
- Hepatology top 10%
Papers in
-
- Urinary Tract Infections Management 2
-
- Antimicrobial Resistance in Staphylococcus 2
- Amoebic Infections and Treatments 1
- Co-authors
- Jan Verhaegen (4 shared papers)André Geubel (2 shared papers)Jean Henrion (2 shared papers)M. Hautekèete (2 shared papers)Jacques Rahier (2 shared papers)R Brenard (2 shared papers)P. Michielsen (3 shared papers)Yves Horsmans (1 shared paper)
In The Last Decade
L Verbist
13 papers receiving 407 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 180
- Hepatology 91
- Molecular Medicine 50
- Pharmacology 122
- Clinical Biochemistry 38
Countries citing papers authored by L Verbist
This map shows the geographic impact of L Verbist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Verbist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Verbist more than expected).
Fields of papers citing papers by L Verbist
This network shows the impact of papers produced by L Verbist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Verbist. The network helps show where L Verbist may publish in the future.
Co-authors
The 25 scholars most cited alongside L Verbist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 193 | |
| 2 | 1995 | 78 | |
| 3 | 1981 | 40 | |
| 4 | 1998 | 33 | |
| 5 | 1995 | 32 | |
| 6 | 1981 | 18 | |
| 7 | 1996 | 15 | |
| 8 | 1994 | 13 | |
| 9 | Diagnosis of amoebic infection of the liver: report of 36 cases. | 1995 | 11 |
| 10 | 1989 | 10 | |
| 11 | 1996 | 8 | |
| 12 | 1990 | 6 | |
| 13 | 1990 | 4 |
About L Verbist
L Verbist is a scholar working on Epidemiology, Infectious Diseases, Pharmacology, Molecular Medicine and Clinical Biochemistry, having authored 13 papers that have together received 461 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Salmonella and Campylobacter epidemiology (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Urinary Tract Infections Management (2 papers) and Amoebic Infections and Treatments (1 paper). The work is most often cited by research in Pharmacology (180 citations), Hepatology (91 citations), Molecular Medicine (50 citations), Pharmacology (122 citations) and Clinical Biochemistry (38 citations). L Verbist has collaborated with scholars based in Belgium, Vietnam and Germany. Frequent co-authors include Jan Verhaegen, André Geubel, Jean Henrion, M. Hautekèete, Jacques Rahier, R Brenard, P. Michielsen, Yves Horsmans, P Yap and Christian Demanet. Their work appears in journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, European Journal of Endocrinology and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.